Six-year-old Ostro rebranded from RxDefine in 2022 after receiving an additional $45 million in funding from investors, bringing its total funding at the time to $55 million. Details of Havas’
investment were not disclosed.
Six-year-old Ostro rebranded from RxDefine in 2022 after receiving an additional $45 million in funding from investors, bringing its total funding at the time to $55 million. Details of Havas’
investment were not disclosed.